An Ultrahigh Affinityd-Peptide Antagonist of MDM2

Journal of Medicinal Chemistry - United States
doi 10.1021/jm3005465
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)

Related search

Structure of a Stapled Peptide Antagonist Bound to Nutlin-Resistant Mdm2

PLoS ONE
Multidisciplinary
2014English

A Stapled Peptide Antagonist of MDM2 Carried by Polymeric Micelles Sensitizes Glioblastoma to Temozolomide Treatment Through P53 Activation

Journal of Controlled Release
Pharmaceutical Science
2015English

Stereoisomerism of Stapled Peptide Inhibitors of the P53-Mdm2 Interaction: An Assessment of Synthetic Strategies and Activity Profiles

Chemical Science
Chemistry
2019English

Phase 1 Study of the MDM2 Antagonist RO6839921 in Patients With Acute Myeloid Leukemia

Investigational New Drugs
OncologyPharmacology
2020English

Structures of Low Molecular Weight Inhibitors Bound to MDMX and MDM2 Reveal New Approaches for P53-MDMX/Mdm2 Antagonist Drug Discovery

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2010English

A Peptide Antagonist of the TLR4-MD2 Interaction

ChemBioChem
Organic ChemistryBiochemistryMolecular MedicineMolecular Biology
2009English

A Dimethylbromobenzene-Cysteine Stapled Peptide Dual Inhibitor of the P53-Mdm2/MDMX Interactions

Hepatoma Research
2019English

An Unconventional Ultrahigh Vacuum Facility

Vacuum
SurfacesInstrumentationCoatingsCondensed Matter PhysicsFilms
1967English

P53 Mediated Death of Cells Overexpressing MDM2 by an Inhibitor of MDM2 Interaction With P53

Oncogene
Cancer ResearchGeneticsMolecular Biology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy